FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

SA Plotkin

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Concepts & Ideas

Immunization Schedule

Procedures

Physiology

Co-author Network

Publications

TOP 3
Stuart P Adler; SA Plotkin; Eva Gonczol; Michel Cadoz; Claude Meric; J B Wang; P Dellamonica; Al M Best; John Zahradnik; S Pincus; Klara Berencsi; WI Cox; zsofia gyulai
A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).
Stuart P Adler; S H Hempfling; S E Starr; SA Plotkin; S Riddell
Safety and immunogenicity of the Towne strain cytomegalovirus vaccine.
SA Plotkin; Michel Cadoz
Acellular vaccine efficacy trials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of SA Plotkin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

1999: Stuart P Adler; SA Plotkin; Eva Gonczol; Michel Cadoz; Claude Meric; J B Wang; P Dellamonica; Al M Best; John Zahradnik; S Pincus; Klara Berencsi; WI Cox; zsofia gyulai
A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).
The Journal of infectious diseases 1999;180(3):843-6.
1998: Stuart P Adler; S H Hempfling; S E Starr; SA Plotkin; S Riddell
Safety and immunogenicity of the Towne strain cytomegalovirus vaccine.
The Pediatric infectious disease journal 1998;17(3):200-6.
1997: SA Plotkin; Michel Cadoz
Acellular vaccine efficacy trials.
The Pediatric infectious disease journal 1997;16(9):913-4.
1997: SA Plotkin; Michel Cadoz
The acellular pertussis vaccine trials: an interpretation.
The Pediatric infectious disease journal 1997;16(5):508-17; discussion 517-9.
1997: SA Plotkin
The effectiveness of whole-cell pertussis vaccines.
Developments in biological standardization 1997;89():171-4.
1996: H Fred Clark; Paul A Offit; R W Ellis; J J Eiden; D Krah; Alan Shaw; M Pichichero; John Treanor; F E Borian; Louis M Bell; SA Plotkin
The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants.
The Journal of infectious diseases 1996;174 Suppl 1():S73-80.
1996: J B Wang; Stuart P Adler; S Hempfling; Rae Lyn Burke; A M Duliège; S E Starr; SA Plotkin
Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines.
The Journal of infectious diseases 1996;174(2):387-92.
1996: Klara Berencsi; Eva Gönczöl; Valeria Endresz; J Kough; S Takeda; zsofia gyulai; SA Plotkin; R F Rando
The N-terminal 303 amino acids of the human cytomegalovirus envelope glycoprotein B (UL55) and the exon 4 region of the major immediate early protein 1 (UL123) induce a cytotoxic T-cell response.
Vaccine 1996;14(5):369-74.
1996: SA Plotkin; M A Fletcher
Developments in immunization practices and strategies: implications for vaccine stability.
Developments in biological standardization 1996;87():85-94.
1995: SA Plotkin; N Bouveret-Le Cam
A new typhoid vaccine composed of the Vi capsular polysaccharide.
Archives of internal medicine 1995;155(21):2293-9.
1995: Eva Gönczöl; K Berensci; S Pincus; Valeria Endresz; C Méric; E Paoletti; SA Plotkin
Preclinical evaluation of an ALVAC (canarypox)--human cytomegalovirus glycoprotein B vaccine candidate.
Vaccine 1995;13(12):1080-5.
1995: Stuart P Adler; S E Starr; SA Plotkin; S H Hempfling; J Buis; M L Manning; Al M Best
Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age.
The Journal of infectious diseases 1995;171(1):26-32.
1995: SA Plotkin; M Cadoz; B Meignier; C Méric; Odile Leroy; Jean-Louis Excler; Jim Tartaglia; E Paoletti; E Gonczol; G Chappuis
The safety and use of canarypox vectored vaccines.
Developments in biological standardization 1995;84():165-70.
1994: SA Plotkin
Problems in the choice of combined vaccines for Europe.
Biologicals : journal of the International Association of Biological Standardization 1994;22(4):411-4.
1994: Klara Berencsi; A Uri; Tibor Valyi-Nagy; I Valyi-Nagy; B Meignier; F V Peretz; R F Rando; SA Plotkin; Eva Gönczöl
Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted viruses.
Laboratory investigation; a journal of technical methods and pathology 1994;71(3):350-8.
1993: Klara Berencsi; R F Rando; C deTaisne; E Paoletti; SA Plotkin; E Gonczol
Murine cytotoxic T cell response specific for human cytomegalovirus glycoprotein B (gB) induced by adenovirus and vaccinia virus recombinants expressing gB.
The Journal of general virology 1993;74 ( Pt 11)():2507-12.
1993: R Gupta; E Gonczol; M L Manning; S Starr; B Johnson; George F Murphy; SA Plotkin
Delayed type hypersensitivity to human cytomegalovirus.
Journal of medical virology 1993;39(2):109-17.
1993: B M Watson; S A Piercy; SA Plotkin; Stuart E Starr
Modified chickenpox in children immunized with the Oka/Merck varicella vaccine.
Pediatrics 1993;91(1):17-22.
1993: SA Plotkin
An end to Manicheism.
Public health reviews 1993;21(1-2):135-8.
1991: Stuart E Starr; H M Friedman; SA Plotkin
The status of cytomegalovirus vaccine.
Reviews of infectious diseases 1991;13 Suppl 11():S964-5.
1991: Barbara J Kuter; R E Weibel; Harry A Guess; Holly Matthews; D H Morton; B J Neff; P J Provost; B A Watson; Stuart E Starr; SA Plotkin
Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies.
Vaccine 1991;9(9):643-7.
1991: Dean Blumberg; C M Mink; James D Cherry; C Johnson; R Garber; SA Plotkin; B Watson; G A Ballanco; Robert S Daum; B Sullivan
Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. The APDT Vaccine Study Group.
The Journal of pediatrics 1991;119(2):194-204.
1991: W Z Ho; V Ayyavoo; A Srinivasan; M F Stinski; SA Plotkin; Eva Gönczöl
Human immunodeficiency virus type 1 tat gene enhances human cytomegalovirus gene expression and viral replication.
AIDS research and human retroviruses 1991;7(8):689-95.
1991: G Hirka; K Prakash; H Kawashima; SA Plotkin; Peter W Andrews; Eva Gönczöl
Differentiation of human embryonal carcinoma cells induces human immunodeficiency virus permissiveness which is stimulated by human cytomegalovirus coinfection.
Journal of virology 1991;65(5):2732-5.
1991: G S Marshall; Stuart E Starr; C L Witzleben; Eva Gönczöl; SA Plotkin
Protracted mononucleosis-like illness associated with acquired cytomegalovirus infection in a previously healthy child: transient cellular immune defects and chronic hepatopathy.
Pediatrics 1991;87(4):556-62.
1991: W Z Ho; Eva Gönczöl; A Srinivasan; S D Douglas; SA Plotkin
Minitransfection: a simple, fast technique for transfections.
Journal of virological methods 1991;32(1):79-88.
1991: H Kawashima; S Bandyopadhyay; Richard M Rutstein; SA Plotkin
Excretion of human immunodeficiency type 1 in the throat but not in urine by infected children.
The Journal of pediatrics 1991;118(1):80-2.
1990: G S Marshall; Robert P Ricciardi; R F Rando; J Puck; R W Ge; SA Plotkin; Eva Gönczöl
An adenovirus recombinant that expresses the human cytomegalovirus major envelope glycoprotein and induces neutralizing antibodies.
The Journal of infectious diseases 1990;162(5):1177-81.
1990: SA Plotkin; Stuart E Starr; H M Friedman; E Gonczol; K Brayman
Vaccines for the prevention of human cytomegalovirus infection.
Reviews of infectious diseases 1990;12 Suppl 7():S827-38.
1990: H Fred Clark; F E Borian; K Modesto; SA Plotkin
Serotype 1 reassortant of bovine rotavirus WC3, strain WI79-9, induces a polytypic antibody response in infants.
Vaccine 1990;8(4):327-32.
1990: H Fred Clark; F E Borian; SA Plotkin
Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3.
The Journal of infectious diseases 1990;161(6):1099-104.
1990: A M Arbeter; L Granowetter; Stuart E Starr; B Lange; R Wimmer; SA Plotkin
Immunization of children with acute lymphoblastic leukemia with live attenuated varicella vaccine without complete suspension of chemotherapy.
Pediatrics 1990;85(3):338-44.
1990: W Z Ho; J M Harouse; R F Rando; Eva Gönczöl; A Srinivasan; SA Plotkin
Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1.
The Journal of general virology 1990;71 ( Pt 1)():97-103.
1989: Louis M Bell; S J Naides; P Stoffman; Richard L Hodinka; SA Plotkin
Human parvovirus B19 infection among hospital staff members after contact with infected patients.
The New England journal of medicine 1989;321(8):485-91.
1989: SA Plotkin; Stuart E Starr; H M Friedman; Eva Gönczöl; R E Weibel
Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge.
The Journal of infectious diseases 1989;159(5):860-5.
1989: Eva Gönczöl; J Ianacone; G Furlini; W Ho; SA Plotkin
Humoral immune response to cytomegalovirus Towne vaccine strain and to Toledo low-passage strain.
The Journal of infectious diseases 1989;159(5):851-9.
1988: H Fred Clark; F E Borian; Louis M Bell; K Modesto; Vera S Gouvea; SA Plotkin
Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season.
The Journal of infectious diseases 1988;158(3):570-87.
1988: Louis M Bell; H Fred Clark; Paul A Offit; P H Slight; A M Arbeter; SA Plotkin
Rotavirus serotype-specific neutralizing activity in human milk.
American journal of diseases of children (1960) 1988;142(3):275-8.
1988: Robert Wasserman; C S August; SA Plotkin
Viral infections in pediatric bone marrow transplant patients.
The Pediatric infectious disease journal 1988;7(2):109-15.
1986: A M Arbeter; L Baker; Stuart E Starr; B L Levine; E Books; SA Plotkin
Combination measles, mumps, rubella and varicella vaccine.
Pediatrics 1986;78(4 Pt 2):742-7.
1986: A M Arbeter; Stuart E Starr; SA Plotkin
Varicella vaccine studies in healthy children and adults.
Pediatrics 1986;78(4 Pt 2):748-56.
1986: E Gonczol; G Furlini; J Ianacone; SA Plotkin
A rapid microneutralization assay for cytomegalovirus.
Journal of virological methods 1986;14(1):37-41.
1986: Eva Gönczöl; F Hudecz; J Ianacone; B Dietzschold; S Starr; SA Plotkin
Immune responses to isolated human cytomegalovirus envelope proteins.
Journal of virology 1986;58(2):661-4.
1986: A M Arbeter; L Baker; Stuart E Starr; SA Plotkin
The combination measles, mumps, rubella and varicella vaccine in healthy children.
Developments in biological standardization 1986;65():89-93.
1985: SA Plotkin; R E Weibel; G Alpert; Stuart E Starr; H M Friedman; S R Preblud; J Hoxie
Resistance of seropositive volunteers to subcutaneous challenge with low-passage human cytomegalovirus.
The Journal of infectious diseases 1985;151(4):737-9.
1984: A M Arbeter; Stuart E Starr; S R Preblud; T Ihara; P M Paciorek; D S Miller; C M Zelson; E A Proctor; SA Plotkin
Varicella vaccine trials in healthy children. A summary of comparative and follow-up studies.
American journal of diseases of children (1960) 1984;138(5):434-8.
1984: S R Preblud; A M Arbeter; E A Proctor; Stuart E Starr; SA Plotkin
Susceptibility of vaccine strains of varicella-zoster virus to antiviral compounds.
Antimicrobial agents and chemotherapy 1984;25(4):417-21.
1983: A M Arbeter; Stuart E Starr; R E Weibel; B J Neff; SA Plotkin
Live attenuated varicella vaccine: the KMcC strain in healthy children.
Pediatrics 1983;71(3):307-12.
1982: H Kamiya; Stuart E Starr; A M Arbeter; SA Plotkin
Antibody-dependent cell-mediated cytotoxicity against varicella-zoster virus-infected targets.
Infection and immunity 1982;38(2):554-7.
1982: A M Arbeter; Stuart E Starr; R E Weibel; SA Plotkin
Live attenuated varicella vaccine: immunization of healthy children with the OKA strain.
The Journal of pediatrics 1982;100(6):886-93.
1980: M D Tolpin; Stuart E Starr; A M Arbeter; SA Plotkin
Inactivated mouse cytomegalovirus vaccine: preparation, immunogenicity, and protective effect.
The Journal of infectious diseases 1980;142(4):569-74.